SARS-CoV-2 & Influenza A/B Antigen Kit
The Goldsite SARS-CoV-2 and influenza A/B antigen kit is a combo rapid test that differentiates COVID-19 from influenza A and B in roughly 10 minutes. Dual-target screening helps primary care and hospital triage areas in Pakistan during overlapping flu and coronavirus seasons when syndromic presentation alone is inconclusive. Package options include 1, 5, and 25 tests per kit. The product is listed under Goldsite’s COVID-19 assay line with colloidal gold rapid immunoassay technology as described in manufacturer materials. Collect and process specimens exactly as specified in the kit insert—typically anterior nasal or nasopharyngeal swabs depending on SKU configuration. Qualitative results should be confirmed per local protocols when clinical suspicion remains high. Keep kits stored within label conditions before use. Zymotic Diagnostics International supplies Goldsite combo respiratory antigen kits alongside other COVID-19 and influenza rapid tests.




